Investing.com - Jaguar Health (NASDAQ: JAGX) reported first quarter EPS of $-2.3900, $2.33 worse than the analyst estimate of $-0.0600. Revenue for the quarter came in at $1.97M versus the consensus estimate of $3.9M.
Jaguar Health's stock price closed at $0.6600. It is down -76.3400% in the last 3 months and down -97.7800% in the last 12 months.
Jaguar Health saw 1 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Jaguar Health's stock price’s past reactions to earnings here.
According to InvestingPro, Jaguar Health's Financial Health score is "fair performance".
Check out Jaguar Health's recent earnings performance, and Jaguar Health's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar